|
Friday
June 28, 2002
• Novel Drug Targets for Treatment of Tuberculosis Identified
•
Bio-Rad
Announces Purchase of Virtek Biotech's Microarray And Robotic Technologies
• GeneCopoeia Announces the Availability of More Than 8,000
Open Reading Frame Clones of Full Length Human Genes
• Gene
Logic Signs GeneExpress CustomSuite Agreement with Schering-Plough
Thursday
June 27, 2002
• SYN X Gets U.S. Patent Allowance For Heart Failure Test
• LSBC
Contracts to Manufacture and Supply Growers Research Group with Lysozyme
Material
• Structural GenomiX Appoints Ian McDonald as VP of Drug Discovery
• InforMax
in Licensing Agreement with the U of Louisville and the U of
Kentucky
•
Genzyme
Molecular Oncology Presents on Powerful Genomics Technology At Immunology
Conference
Wednesday
June 26, 2002
•
SYN
X Enrolls First Canadian Patients in Government Approved Trial for
Diagnosing Alzheimer's
•
New
D&MD Report -- GPCRs: The Targets of Today's Drugs And Tomorrow's
Blockbusters
• The
Scientific Journal Blood Publishes a Second Article on Celmed
BioSciences' Technology
Tuesday
June 25, 2002
• LSBC
Announces Collaboration with StemCell Technologies on PLURIGEN
CM Cell Cultivation Product
•
ZYCOS Receives Milestone Payment From Aventis for Novel Antigen Discoveries
• Invitrogen
Launches Integrated Services Platform to Build the Human ORFeome: ORFeome
BioCharter Program Bridges Genomics and Proteomics
• Venter to Present Opening Keynote Address at BioITWorld
San Diego
• Genetronics
to Be One of Four Companies Presenting at CCG Biotechnology Conference
• Structural
Bioinformatics Taps Industry Expert to Lead Drug Discovery Efforts
• Auburn University Selects InforMax Software for Broad
Deployment
•
Genetastix
Further Strengthens Intellectual Property Position
•
Frost
& Sullivan Honors Acero With 2002 Product Innovation Award For
Facilitating the Next Generation of In Silico Applications
Monday
June 24, 2002
• Zyomyx Forms Comprehensive Alliance with Partners Healthcare
•
OGS Receives Complete Response Letter from the FDA on Vevesca (OGT
918)
•
OGS
Shares Tumble After Key Drug Hits FDA Roadblock
•
Clearing
The Genomics Bottleneck
• LumiCyte
Signs Distribution Agreement with Shimadzu Expanding Global Reach
to Japan
• Protein repairs damaged rat brains after stroke
•
Genzyme
Molecular Oncology and Silico Insights Sign Agreement To Co-Market
Genomics Technologies
•
Abbott
and Celera Diagnostics Form Alliance to Develop and Market
Molecular Diagnostic Products
Friday
June 22, 2002
• Microarray Slide Developer Accelr8 Hopes to Close
Inaugural Licensing Deals by July
•
Issues
in Patenting of Genomics-based Inventions & Gene Sequences Featured Heavily
at IP Conference in Philadelphia, PA, July 18-19, 2002
Thursday
June 21, 2002
• Biogen and SurroMed Announce Collaborative Research
Agreement for Comprehensive Phenotyping and Biological Marker Discovery
•
Strand Genomics and Automated Cell in Strategic Bioinformatics
Partnership
Wednesday
June 20, 2002
• Zyomyx Announces Issuance of Third Protein Chip Patent
•
Gene Expression Profiles Predict Survival of Lymphoma Patients After
Chemotherapy
•
Genetronics
Announces the Sale of Its BTX® Division To ICN for $5 Million
• Beyond Genomics Appoints Jim Hauske, PhD, CSO
Tuesday
June 19, 2002
• Prolinx Signs a Distribution Agreement with Milian
for RapXtract Superparamagnetic Separation Technology
• Panacea
Named 2002 Maryland Incubator Company of the Year
• AxCell and NCI Sign Letter of Intent to Enter Into a Second
Cooperative Research and Development Agreement
• MorphoSys Issued European Patent for HuCAL® Antibody
Technology
Monday
June 18, 2002
•
Phylos
Awarded Phase II SBIR Grant to Develop Protein Microarrays Using TRINECTIN™
Binding Proteins
•
Dr. Tom Vasicek to Lead Lynx Business Development Efforts
•
What
Supercomputers Can and Can Not Do - Yet
Friday
June 14, 2002
•
LSBC
Announces Collaboration With National U of Singapore Using PLURIGEN
CM Cell Cultivation Product
•
Genomic Solutions received a notice from the Nasdaq
• Syrrx Forms Research Collaboration With Sankyo
• ProMetic Life Sciences Increases Financing to $26.2 Million
• LifeSpan
Biosciences Achieves Corporate Milestone, Deploying New Automated
System for Industrial-scale Image Collection and Analysis
Thursday
June 13, 2002
•
0ver
150 to Attend Inflammation & Protein Kinases in Drug Discovery & Development
Meeting
•
Protein Polymer Technologies Reports Increase in Contract Revenue
•
Pharmacor
Receives U.S. Patent for HIV Protease Inhibitor
Wednesday
June 12, 2002
• Protein Discovered That Keeps Hemoglobin in Balance
•
AnVil
Announces Collaboration with Applied Biosystems in Hunt for 'Dark
Genes'
• The World Antibody Community to Convene at Display Technologies
in Drug Discovery Conference in Long Branch, NJ, Sept. 19-20, 2002
• Cognia
Announces that Leading Academic Institutes Subscribe to TRANSFAC Professional
and Associated Databases
Tuesday
June 11, 2002
• Varian Receives First European 900MHz NMR Order from Swedish
NMR Centre
• Celera
Implements Restructuring
• Cognia
Accelerates its Curation and Protein Informatics Program With Key Appointments
• MDS Sciex Recognized With Technology Transfer Award
Monday
June 10, 2002
• LSBC and Phylogix Form Bioprocessing Alliance: Goal
to produce therapeutic plant protein to alleviate tissue damage by chemotherapy
•
Institute for Systems Biology Turns to IBM for Linux Solutions
• Leading
Proteomics Companies And Investors To Present At Proteomics Leadership
Forum In New York June 13, 2002
• SYN X Founder to be Featured at BIO 2002
• Prolinx Signs Distribution Agreement with Daiichi Pure
Chemicals
• IBM
and Molecular Mining Team to Advance Drug Discovery
• GeneFormatics
Expands Drug Discovery Team
Friday
June 7, 2002
•
The
Protein Project: With human genes mapped, scientists ponder the proteome-
San Diego Tribune
• Syn X Pharma Inc. to be Featured at BIO 2002
•
engeneOS Appoints Renowned Scientist to SAB; Obtains Exclusive License
to Protein Engineering Technology From the Penn State
•
Genetronics
Announces $4.3 Million Private Placement
• BIO
2002 Exhibitor Profiles
• HUPO President Throws Down the Gauntlet
Thursday
June 6, 2002
•
Invitrogen
Launches the ZOOM Proteomics System, Enables 2D Protein Separation in
Hours Instead of Days, Facilitates High Throughput Proteomic Research
• Waters Announces Modification of Technology Contract with
GeneProt
•
Roche
and Genmab Announce Major Expansion of Antibody Collaboration,
Roche to Invest $20 Million in Genmab
•
Applied
Biosystems/MDS Sciex announce Canadian introduction of new
system for protein and metabolite analysis at BIO 2002
• Biacore Receives USD 2 Million in Damages From Thermo
BioAnalysis Corp; Damages Paid for Infringement of Biacore
U.S. Patent Position
• GPC Biotech Announces Out-Licensing of Antibacterials Program
to PanTherix
•
Protein
Phosphatases Drug Discovery Conference to Feature Latest Industry & Academic
Research Advances in Philadelphia, PA, September 26-27, 2002
• Nonlinear
Dynamics Further Strengthens Presence in Asia With New Distributor
in Thailand
Wednesday
June 5, 2002
•
Phylos
and Upstate to Collaborate on TRINECTIN™ Binding Proteins
for Protein Array Development
•
Applied
Biosystems/MDS Sciex announce Canadian preview of new system
for protein and metabolite analysis at Bio 2002 press conference
Tuesday
June 4, 2002
•
Lynx Appoints Kevin Corcoran as New President and CEO
•
Cytogen
Completes $5 Million Private Offering of Common Stock; State of Wisconsin
Investment Board Increases Investment in Cytogen
• LSBC
Announces Major Reorganization: Initial Annual Cash Expense Reduction
of $10 Million to Enhance Operating Capital for Commercialization of Pipeline
Products ; LSBC
to Host Conference Call
•
Thermo
Finnigan Introduces the TRACE DSQ™ - Your Essential Lab Partner
For GC/MS Sensitivity
•
ActivX
and Kyorin Pharmaceutical Sign Drug Discovery Agreement for Diabetes
Program
• Bruker Daltonics Launches MetaboliteTools Software
• Signature
Signs With geneticXchange for Its discoveryHub Data Integration
Solution
Monday
June 3, 2002
• Proteome Systems and ITOCHU Launch Proteomics Company
in Japan
•
Leading
Researchers to Present Protein Biomarker Discoveries Using Ciphergen's
SELDI ProteinChip® Platform at ASMS Meeting
• Leaders In Applied Genomics Join Forces to Host National
Seminar Series
•
Genomic
Solutions Releases Proteomics Bioinformatic Solution
• Amersham
Biosciences Introduces New Protein Identification Technology Specifically
Designed for Proteomics Applications at ASMS Meeting
•
HUPO,
Amersham Road Show to Toot Proteomics
• HUPO Educational Forum Promotes Biological Research Technology
• Bruker
Daltonics and GeneProt Announce Upgrade of GeneProt's
Mass Spectrometry Capabilities for its Geneva Proteomics Factory
• Bruker Daltonics Announces New 12 Tesla Ultra-High Field
FTMS Magnet
• Bruker
Daltonics Announces Further Enhanced TOF/TOF Performance
• Bruker
Daltonics Pioneers Ion Trap Accurate Mass Methods for Proteomics
• Bruker
Daltonics Introduces Innovative CombiSource for FTMS
• Bruker
Daltonics Announces Advanced HyStar LC/MS Software
Friday
May 31, 2002
•
Proteome
Systems Launches ProteomIQ™, A Next Generation Platform For Proteomics
Research
•
Nutra Pharma Signs Definitive Agreement to Acquire Bio Therapeutics
Thursday
May 30, 2002
•
Technology
Transfer Forum at BIO 2002 in Toronto; Featuring 19 Canadian Companies,
Research Organizations and Universities
•
Genomics One issues results of second quarter ended March 31, 2002
• Celera
Publishes Analysis of Mouse Chromosome
Wednesday
May 29, 2002
• Applied
Biosystems Introduces New System for Protein and Metabolite Analysis
at American Society of Mass Spectrometry Conference
•
Dr. Daniel Chelsky Joins Caprion as CSO
•
Genetronics
Names Wells Fargo as Corporate Financial Advisor
• The
National Center for Genome Resources Appoints Geert Wenes, Ph.D.,
As Program Leader of Bioinformatics
• Cytogen Sees 2002 Revenue $12.5M-$14.5 Million
•
New
Targets & Candidates for Treatment of Metabolic Diseases & Cancer To Be
Featured at Nuclear Receptor Conference Newark, NJ July 22-23
•
Lynx
Announces Initiation of Gene Expression Analysis Services For the National
Cancer Institute
Tuesday
May 28, 2002
• PerkinElmer Life Sciences Discloses Details of New ProteinArray
Workstation
• Gyros
AB and Kratos Analytical Begin Development Collaboration
• Peptide
Assay Development Facilitated by Versalinx Tools
•
WITA
Proteomics - Pharmagene Alliance Completes Research Milestone in Drug
Development Programme
Friday
May 24, 2002
• OGS Appoints New CEO
•
Bruker Daltonics to Host Analyst Tour at ASMS Conference
•
The
GSAS Harvard Biotechnology Club Announces the Winners of the Third Annual
Biotechnology Business Plan Competition
• Nonlinear
Dynamics appoints J & H Technology as Exclusive Distributor
in Taiwan
• Applied Biosystems/MDS Get Injunction Versus Micromass
Thursday
May 23, 2002
• Myriad BRACAnalysis Test Supported by Two New Studies; BRACAnalysis
Essential in Saving Lives From Breast and Ovarian Cancer
• UPSIDE
Magazine and MIT's Technology Review Recognize Syrrx Excellence
with Awards
• Sigma-Aldrich
and Chromagen Announce Collaborative Agreement to Develop Next-Generation,
Fluorescence-Based Assays for Drug Discovery & Life Science Research
• Genetronics Arranges Private Placement of US$3,300,000
• Genomic Solutions Names Ernst & Young as Independent Auditor
Wednesday
May 22, 2002
• David
Weitz Completes Syrrx Senior Management Team as VP of IP and GC
• Stressgen strengthens board with Canadian MDS executive
Ian Lennox
• Bayer
Scientists Demonstrate Plasma Purification Processes Have the Potential
to Remove Pathogenic Form of Human Prion Protein
• Amersham Biosciences Creates Linnaeus Chair At Muhlenberg
College
•
Caliper
Gets a VP; Genops Taps New Director
•
German
Academic Competence Network 'Pathogenomik' and GeneData Agree On
A Collaboration to Study Pathogenic Bacteria
•
GeneData Expands Its Software Portfolio For Drug Discovery With the
Release Of GeneData Screener™ For High-Throughput Screening Data
Analysis
Tuesday
May 21, 2002
• Lynx Announces Initiation of a Showcase Study With Institute
for Systems Biology
•
GPC
Biotech Expands Research and Development Management Team
•
GPC
Biotech US Facility Operating Chief Resigns; 4 New Staff
•
CuraGen
Announces CG53135 Protein Demonstrates Reproducible Efficacy in Multiple
Models of Inflammatory Bowel Disease
Monday
May 20, 2002
•
BU
School of Medicine and Beyond Genomics form Strategic Research
Alliance
• Matritech
and Bruker Daltonics Announce Partnership for Proteomics-Based
Cancer Screening by Mass Spectrometry
• Progenics and Cytogen Identify New Therapeutic Agent
for Prostate Cancer
• Applied
Biosystems to Webcast June 2 Investor Meeting At American Society
of Mass Spectrometry Conference
• American
Pharmaceutical Partners Presents Phase II Trial Results in Metastatic
Breast Cancer for ABI-007, a Novel Protein-Engineered Nanoparticle Form
Of Leading Cancer Agent Paclitaxel
• PerkinElmer Introduces the First Data and Visualization
Software Solution to Effectively Manage Entire Gene Expression Process
Friday
May 17, 2002
•
Prolinx
Awarded Frost & Sullivan 2002 Technology Innovation Award for Proteomics
Platform Technology
•
Caliper Sues Molecular Devices for Patent Infringement
Thursday
May 16, 2002
• LabBook,
Lextant and Entara Partner to Bring Knowledge Management
Solutions to Life Science Companies
•
MorphoSys
Acquires Anti-Cancer Antibodies From ProChon; ProChon Expands
Existing Collaboration With MorphoSys
• Myriad Launches Fifth Predictive Medicine Product
•
AnVil
and ClinQuest Announce Marketing Partnership
•
Thermo
Electron to Buy its Own Securities
Wednesday
May 15, 2002
• Accelrys Announces Global Licensing Agreement With Lilly
•
Zyomyx
Delivers First Protein Profiling Biochip™ Unit
• Myriad Genetics Launches Fifth Predictive Medicine Product
Tuesday
May 14, 2002
• Panacea Announces Closing of Series B Private Placement
• Bruker
AXS Completes Acquisition of MAC Science
• Amersham
Biosciences To Take Controlling Stake in Cimarron, Leading
Informatics Company
Monday
May 13, 2002
• Caliper Announces Executive Management Succession Plan
•
MDS
Proteomics Named to the Red Herring 100
•
Maxygen
Announces Major Advances in Its MolecularBreeding™ Product Discovery
Platform
• Genmab and ACE BioSciences Collaborate to Treat Infectious
Disease
•
Phylos
and Avalon Pharmaceuticals to Collaborate on Drug-Protein Interaction
Assay Development
•
GPC
Biotech Receives Orphan Medicinal Product Designation in Europe for
Clinical Phase II Oncology Compound
• GPC Biotech Posts Strong First Quarter 2002
• SYN X Pharma Obtains U.S. Patent Allowance For Its Alzheimer's
Disease Diagnostic Device - Blood Test Could Lead To Earlier Detection
Of Alzheimer's
•
The
Scientist: Mass Spec-tacular
•
The
Scientist: Double TOF; Applied Biosystems unveils the first commercially
available tandem time-of-flight mass spectrometer
• The Scientist: Out-of-the-Box Proteomics Analysis; Thermo
Finnigan's ProteomeX is an all-in-one LC/MS with software
•
The
Scientist: Negative News; Micromass expands its M@LDI family with
negative-ion detection capabilities
Friday
May 10, 2002
• Illumina Receives $1.0 Million Phase 2 SBIR Grant From the
National Institutes of Health to Develop Matrixed Microarrays
Thursday
May 9, 2002
• MDS Proteomics and Thermo Finnigan to Collaborate
on Design of Next-Generation Technology to Dramatically Accelerate Proteomics-Based
Drug Discovery
•
New
Targets for Treatment of Metabolic Diseases & Cancer to Be Featured At
Nuclear Receptor Conference Newark, NJ, July 22-23
• To Be a Tools Company, Or Not? Ciphergen Asks the
Question
Wednesday
May 8, 2002
• SYN X Pharma Reports Improved Financial Position in 2001
•
Affinium Announces Strategic Alliance With Pfizer
Tuesday
May 7, 2002
• Biacore Interim Report January - March 2002
•
AnVil
Receives Two Grants from National Institutes of Health To Help Discover
Potential Cancer Drugs
• Myriad Reports Results for Q3 of Fiscal 2002
• Astex and Maybridge Announce Exclusive Lead Discovery
Collaboration
• Matritech
Reports First Quarter Financial Results
•
BioForce
Nanosciences Announces Collaboration With the NCI and the FDA
Monday
May 6, 2002
• Bruker
Daltonics Q1 2002 Product Revenue Up 23%, Operating Earnings Double
•
QIAGEN
Reports Q1 2002 Results; 23% Revenue Growth in Core Consumables Business
and EPS of $ 0.07
• Heightened Drug Discovery Efforts Drive Protein Array Markets,
Says Frost & Sullivan
•
Affinium
and The Hospital for Sick Children Announce Membrane Protein Proteomics
Initiative Funded by Cystic Fibrosis Foundation Therapeutics, Inc.
•
CHI
Report: Biological Pathways Offer Special Advantages in the Pursuit of
Target Validation
• Caliper Opens European Subsidiary
• Scimagix To Host Technology Workshop at IBC Proteomics 2002
• Structural
Bioinformatics Recruits J & J Executive as Senior Director, National
Sales
• Matritech Announces 2002 Q1 Earnings Conference Call
• BioVisioN
and Novo Nordisk Establish Collaboration
• Kinexus Bioinformatics Completes First Stage Equity Financing
• HUPO
Workshop 2002: Agenda and Report of the BreakoutSession for the Human
Plasma Proteome Project, Cell Model Session, and Proteome Bioinformatics
Session.
Friday
May 3, 2002
• Screentec Changes Its Name to Kiadis; Kiadis
to Implement New Drug Discovery Strategy
•
Can
cancer drug heal Millennium? Biotech firm betting on experimental
drug to revive hopes
• New Boston Genomics Center Brings Tiny Science to the Big
Screen
• Thermo Electron Informatics Group Forms Global Life Science
Alliance with Compaq
Thursday
May 2, 2002
•
OGS
Monotherapy study 001 results on Vevesca (OGT 918) presented at EWGGD
•
Genomic Solutions Expands International Distribution
•
Cytogen
(Axcell) Reports First Quarter 2002 Results
•
Affinium
Recognizes Election of Drs. Tak Wah Mak and Michael Levitt to National
Academy of Sciences
• Rabbit Liver Protein Provides Clues to Improving Cancer
Therapy
• InforMax
and AxCell Announce Amendment to their Strategic Alliance Agreement
• Syrrx Forms High-Throughput Protein Crystallization Collaboration
With Roche
•
Lynx
Reports Financial Results for the Q1 of 2002
•
Aclara
To Present at Deutsche Banc Alex. Brown's Annual Health Care 2002 Conference
on May 8, 2002
• Nonlinear
Dynamics Appoints Chayon Laboratories, Inc. as its Exclusive
Distributor in Korea
Wednesday
May 1, 2002
• Syrrx Files Patent Infringement Suit Against Oculus Pharmaceuticals
•
MelTec
Characterizes Protein Networks Involved in T-cell Invasion - Results of
Two Studies Published in the Journal of Theoretical Medicine
• Caliper Elects Robert C. Bishop, Ph.D. to Its Board of Directors
•
220
Biotech Companies to Present at International BIO 2002 Business
Forum
•
AnVil
Announces Key Technical Hires
•
The
World Genomics Symposium and Exposition Announces a Special Focus
On Building Alliances and Consortium Development
Tuesday
April 30, 2002
•
AxCell
Enters into Second Research Collaboration with Mount Sinai School of Medicine
•
Lynx Completes $22.6 Million Private Equity Financing
• Lynx Invites You to Participate in First Quarter 2002 Conference
Call
•
Zyomyx
Appoints New Vice President of Corporate Development
• Bruker
Daltonics to Webcast Q1 Conference Call on May 6, 2002
• Applera
Confirms Share Repurchase Program for Its Applied Biosystems Common
Stock
• InforMax Invites You to Join its 2002 Q1 Results Conference
Call
•
ACLARA
Announces First Quarter 2002 Financial Results
Monday
April 29, 2002
• Applied
Biosystems and HTS Biosystems Enter Alliance to Develop Key
Technology for Functional Proteomics
• Thermo Electron Completes CRS Robotics Acquisition
•
Amersham
plc Reports First Quarter Sales
•
Amersham
Biosciences Dishes Out $500,000 for HUPO Lecture Series and
Annual Meeting
• Beckman
Coulter Announces 20% Net Earnings Increase for Q1 2002
•
Genome
Quebec creates a high technology platform at McGill $ 60 M
of its research portfolio in genomic and proteomic will be dedicated to
this project
• PerkinElmer Awarded U.S. Patent for Industry-Leading Microarray
Innovation (See
Patent 6,355,934: Imaging system for an optical scanner)
Friday
April 26, 2002
•
Applied
Precision's arrayWoRx(e) Auto Biochip Reader Automates White Light-Based
Microarray Scanning
• Protedyne
Announces European Launch of BioCube System at Europe's Largest Biotechnology
Trade Fair
• DiAthegen
& TissueInformatics Announced Drug Target Discovery Alliance for
Obesity and Diabetes
Thursday
April 25, 2002
•
Applied Bio profit falls; sales slow, costs rise
•
Accelrys
to Provide Functional Annotations for Incyte On Proprietary Protein
Sequences
•
Protection
Results Against Malaria, Herpes and Cancer Reported With CEL-SCI's
Newly Discovered Peptide
• Genomic Solutions Reports Record Q1 2002
• ProteEx Presents at The Texas Venture Capital Conference
•
Ciphergen
Reports Q1 2002 Financial Results
• 3-DP Reports Q1 2002 Financial Results
• Biacore: Interim Report, January - March 2002
Wednesday
April 24, 2002
•
Luminex Reports Q1 2002 Results
•
Thermo
Electron Reports Q1 2002 Results
• AxCell Enters Into Strategic Alliance With U of Muenster
To Study Protein Implicated in Neurodegenerative Diseases
•
Genomatica
Enters Into Exclusive Licensing Agreements With U of California and Penn
State
•
Glaucus
Proteomics Enters Into Alliances with Supercomputer Center SARA and
GigaPort to Develop High Throughput Proteomics Tools
• OGS Temporarily Halts Vevesca (OGT 918) Treatment in Israel
as a Precaution Pending Investigation of an Unexplained Adverse Event
•
Compugen
Q1 loss/shr widens
• LSBC
Announces Progress on PLURIGEN CM Commercialization Strategy
Tuesday
April 23, 2002
• Cellzome Appoints Dr. Georg Casari to Vice President, Informatics
•
Athersys
Issued Patent for Secreted Protein Activation, Production
• Icogen Receives NIH Funding for its GPCR Activator Screening
Technology
•
Lynx
and Wilex Sign Cancer Research Collaboration to Characterize Cellular
Changes Induced by WX-G250-Therapy
• DPI Reports Financial Results For First Quarter 2002
•
Imaging
Research Inc. Granted US Patent for Automated Spot Finding Methods
For Micro and Macro Arrays
• engeneOS Names Gordon Wong, D.Phil. as CSO
•
Bio-Rad
Reports Continued Growth in First Quarter of 2002
• Amersham
Biosciences Introduces Ettan DIGE Platform for 2-D Fluorescence Difference
Gel Electrophoresis
• GeneFormatics
and Incyte Sign Agreement to Annotate Functions of Protein Sequences
Monday
April 22, 2002
• Genetronics Announces Formation of Scientific Advisory Board
• Ciphergen
Announces Q1 2002 Earnings and Conference Call
• Bruker Daltonics Receives Frost & Sullivan's 2002 Product
Line Strategy Award
• Applera
Appoints Kathy Ordonez as President of Celera
• Applera
Announces New Applied Biosystems Knowledge Business and Marketing
and Distribution Agreement for Celera Discovery System
Friday
April 19, 2002
• Phylos Names Dr. Edward F. Fritsch as Senior Vice President
of Development
• Applera
Conference Call to Discuss a New Business Initiative for Applied Biosystems
and the Online Information Business of Celera
Thursday
April 18, 2002
• Multiplexed Protein Profiling on Protein Chips Using Rolling
Circle Amplification
• Bruker
AXS Acquires MAC Science to Further Penetrate Japanese Life
Science and Materials Research Markets
• Chemical Genomics -- Linking Drug Activity With Protein
Function
•
Lynx
Announces Workforce Reduction
• Molecular Devices Reports Revenues and Earnings For Q1 Of
2002
• Illumina
Reports Financial Results for Q1 2002
• Nonlinear
Dynamics Receives DTI Smart Award in Recognition and Support of Proteomics
Technology Development
• Structural
Bioinformatics Expands Proteomics-Based Drug Discovery Relationship
with Johnson & Johnson Pharmaceutical Research & Development
Wednesday
April 17, 2002
• Lynx Arranges $22.6 Million in Private Equity Financing
•
MDS Pharma Services Establishes Drug Development Programs Capability
•
Boston
Biomedica Awarded NIH Grant for the Development Of a Test to Detect
Infectious Prion Proteins in Blood
•
Inflammation
& Protein Kinases in Drug Discovery & Development Meeting To be Held June
24-25 Princeton, NJ
• Caliper Files Patent Infringement Suit Against Molecular
Devices
•
AGY
Therapeutics Starts Drug Discovery Program Based on Novel Proprietary
Alzheimer's Disease Target
• Gene Network Sciences Adds New Member to Board of Directors
• LifeSpan
BioSciences Names New CIO
Tuesday
April 16, 2002
•
Oracle Introduces Information Architecture for Life Sciences; Creates
an Open Platform for the Entire Life Sciences Value Chain
•
PharmaGap
Models Proteins on NRC and Lyon University Supercomputers
•
Bio-Rad
to Report Q1 Financial Results on Tuesday, April 23, 2002
• New D&MD Report - Commercial Opportunities in Enzyme
Technologies, 2nd Edition
•
DPI
Announces Significant Drug Discovery Collaboration With Xenon Genetics
Monday
April 15, 2002
• Myriad Publishes Major Obesity Gene Locus
• MOCON
Announces Collaboration with Waters Corporation in the Proteomics
Drug Discovery Market
• Prolinx
and BioDiscovery Announce a Co-Development Collaboration Agreement
• Biotech Automation Company, Korvis Automation Introduces
Korvis Platform
• Molecular
Mining Corporation Releases GeneLinker Platinum, Takes Data Analysis
to the Next Level
• Applied Biosystems and Celera Q3 FY 2002 Financial
Results and Conference Call Scheduled for Release April 25, 2002
• Varian's
New LC-NMR-MS System Helps Pharmaceutical Researchers Develop Safer, More
Effective Drugs
• Accelr8 Technology Introduces Protein Microarray Products
Friday
April 12, 2002
• Bioinformatics Expert Joins AxCell Scientific Advisory
Board
•
Luminex Q1 2002 Financial Results Scheduled for Release April 24,
2002
Thursday
April 11, 2002
• Gyros Increases Successful Second Round Funding
•
LSBC to Release Q2 2002
•
Structural
GenomiX Achieves First Milestone In Determining Structure of Cystic
Fibrosis Protein
•
A
New CHI Report Evaluates Advances in Systems Biology for Uncovering
New Drug Targets
• Zaxis International Reports Year-End 2001 Results
Wednesday
April 10, 2002
•
Dyax Has Granted Over 60 Licenses to Its Phage Display Patent Portfolio
•
Cancer
Researchers Lick Their Chops Over Proteomics -Genomeweb
Tuesday
April 9, 2002
•
MicroMass Communications Names New Board of Director
•
Accelrys
Announces the Release of Catalyst 4.7
• Molecular
Mining Corporation Opens New Business Headquarters in Cambridge, Massachusetts
• Tm Bioscience Licenses Universal Array Technology to MetriGenix
• Bruker
Daltonics Reports Strong Growth in First Quarter Orders for Life-Science
Systems
• Bruker Daltonics-Sponsored American Chemical Society Award
for Outstanding Achievement in Mass Spectrometry Goes to Rockefeller
University Professor
Monday
April 8, 2002
• Biotech
Benchmark Surpassed: LumiCyte Generates Human Serum Protein Maps
with up to 1,500 Features
• Bruker
Daltonics Reports Strong Growth in First Quarter Orders for Life-Science
Systems
• CuraGen Scientists Present Data on Anti-Angiogenic Protein
•
Genomic
Solutions Expects Record First Quarter Sales
•
Thermo
Finnigan Introduces the LCQ™ Deca XP Plus Ion Trap Mass Spectrometer
With Enhanced Ion Optics and Sweep Gas
•
Thermo
Finnigan Announces the Industry's First Combination APPI/APCI Ion
Source for Fast Analysis of Problematic Compounds
• Genencor
to Build Clinical Manufacturing Facility for Therapeutic Proteins
•
Accelrys
Continues to Expand Breadth of Product Offerings Optimized For IBM
Servers
• Affinium
Announces a US $7M Viral Proteomics Program to Prioritize Druggable
Targets to Fight Virus-Induced Disease
•
Harvard
Study Identifies Potential Biomarker for Use in Early Detection of Ovarian
Cancer Using Ciphergen's SELDI ProteinChip® System
Friday
April 5, 2002
•
MelTec
Partners With MyoContract to Develop Therapeutics for Duchenne
Muscular Dystrophy
Thursday
April 4, 2002
• MDS Sciex awarded $17.5 million for large-scale Genome Canada
project
•
Leading
Researchers at AACR Reveal Encouraging Results in the Early Detection
Of Cancer Using Ciphergen's SELDI ProteinChip® Technology
• InforMax
Announces Preliminary First Quarter Results
• Biacore:
Annual General Meeting May 7, 2002; Proposal for Employee Stock Option
Program to be Put Forward
Wednesday
April 3, 2002
•
LifeSpan BioSciences Introduces DrugTarget Database Covering Gene
Families of Greatest Interest to Pharmaceutical Companies
• MetriGenix
and Temple University to Co-Develop Proteomic Chips for Cardiovascular
Disease
• MorphoSys Achieves Milestone With ImmunoGen
• Myriad and DuPont Form $24 Million Research Collaboration
Tuesday
April 2, 2002
•
DataSys
Customer, Phylos Wins Coveted Microsoft Great Plains
Pinnacle Award and Dessert with Bill Gates
•
Luminex plunges on Q1, FY02 warning
• Ambit Biosciences and
AstraZeneca Enter Proteomics Based Research Collaboration
•
Zyomyx Announces
Issuance of Second Protein Chip Patent (See
Patent 6,365,418: Arrays of protein-capture agents and methods of use
thereof)
• Institute for Systems Biology Planning
Second International Symposium
Monday
April 1, 2002
•
Signature BioScience Receives Its Fourth U.S. Patent for MCS Technology
• Lynx
and Aventis CropScience to Develop a New Assay for Plant Analysis
•
Luminex
Provides Preliminary Q1 2002 Financial Outlook
•
Biotech
Recovers Slightly in March
|
